Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

Justification

VIEWS: 30 PAGES: 7

									STANDARD TABLE 10 SYRINGE AVAILABILITY
JUSTIFICATION: The European Council, meeting in Helsinki on 10 and 11 December 1999, endorsed the European Union Drugs Strategy 2000-2004 that covers all European Union drug-related activities and sets main targets. These targets include a substantial reduction over five years of the incidence of drug-related health damage (such as HIV, hepatitis B and C and tuberculosis) and the number of drug-related deaths. The European Union Action Plan on Drugs 2000-2004, endorsed in June 2000 at the European Council meeting in Santa Maria da Feira, transposes the Strategy into concrete actions that follow a comprehensive approach and cover all areas of drug abuse prevention, from discouraging the initial use to reducing the negative health and social consequences. On 18 June 2003, the Council Recommendation on the prevention and the reduction of health-related harm associated with drug dependence (2003/488/EC) was adopted by the European Council. The Recommendation calls on Member States to develop a range of specific services and facilities aiming at risk reduction, including, where appropriate, access to injection materials through syringe exchange programmes and other distribution points. It foresees provisions to be made on reporting at national and Community level to monitor the measures taken by the Member States in this area, and the results hereof, and the way the Recommendation has been implemented. With this Standard Table, data on syringe exchange, distribution and sale are collected with the aim to contribute to the information on the availability of syringes to drug users. It is recommended to involve a national expert group in the information collection for this table.
Version 09/12/2003 DH Rua Cruz de Santa Apolónia 23-25, 1149-045 Lisbon Portugal

Country Reporting year A (i) Date filled in Name Institution E-mail

Not all types of syringe exchange points are available in all countries. 2004,09,07 For few countries, estimates under 'OVERALL SYSTEM' (Row 29) will Roman Bykov be the Central and Eastern European Harm reduction networkmain information they can provide.
romanas@ceehrn.org

Lithuania 2003

GENERAL COMMENT:

If YES: Number of different syringe provision points (iii)

Standard Table 10: Syringe availability

Number of syringes provided (sold, exchanged, distributed)

Modalities of syringe provision (in percent - 100% across the three columns)

Exch

Distr

Sale

yes
Fixed NSPs (ii) NSP through specially equipped van/bus (iv) NSP through street-outreach, incl. peer-distribution (v) Vending machines Prison NSPs Pharmacy/Drugstore syringe exchange/provision Pharmacy / Drugstore syringe sales to drug users Other 1 <PLEASE SPECIFY under no. 2 below> Other 2 <PLEASE SPECIFY under no. 2 below> Unknown type OVERALL SYSTEM:

5 1 1 -

159 366

yes yes -

7075% 144 376 80% 1 774 86% information is not available XXX XXX 100%

506 4 483 30 -

Rua Cruz de Santa Apolónia 23-25, 1149-045 Lisbon Portugal

Number of individual clients of syringe provision in reporting year (see no. 1 below)

Availability in the country (indicate: YES or NO)

Number of client contacts for syringe provision in reporting year (see no. 1 below)

506 4 483 30 -

FURTHER INFORMATION:

1

Please provide references to studies on numbers injecting drug users reached by services. Central and Eastern European Harm Reduction Network in the framework of the joint project with UNAIDS collects information on Harm Reduction projects in the region. The figures are based on the data provided in the database at www.ceehrn.org/maps2

2

Specify other types of syringe provision. The available types of syringe provision were presented above.

3

Please estimate the national geographical coverage of syringe provision and/or the percentage of injecting drug user population covered. For the geographical coverage please refer to the maps at www.ceehrn.org/maps2

4

Please indicate your sources of information, including other experts, working groups or committees involved in providing the information for this table "HIV/AIDS Prevention amongst IDUs in Lithuania, Best Practices" at http://www.ceehrn.org/index.php?ItemId=7166

NOTES:

i

This Standard Table has been agreed to be filled in every two years. It should however contain data for one calender year only (the most recently completed year for which data are available = Reporting Year A). In addition, data from the year before can be provided in the next sheet of this workbook ("Reporting Year B"). Please put '999' when no information is available and 'XXX' when the category is not applicable. Indicate with an asterisk '*', when the value you provided is an estimate and provide further information on the basis of the estimate under no. 4 above.

ii

NSP = Needle and syringe programme, Fixed location: e.g.specialised drug agency, medical/emergency service.

iii

Syringe provision points: individual locations, physically distinct outlets where syringes can be obtained for free, against payment or in exchange against used ones. (e.g. Row 24: Number of pharmacies involved in syringe exchange programmes; Row 25: Total number of pharmacies, in countries where sale of syringes is legal). NSPs from a specially equipped mobile unit (van/bus) that services different locations on a regular basis. Refer in your reply to the number of different sites serviced by mobile unit as 'points'. Most mobile units are linked to and operated from a fixed programme, e.g. drugs agency with NSP. If the number of syringes distributed through the mobile units are not available separately, include the number of syringes provided under 'Fixed NSPs', indicate under 'number of syringes' not available = XXX, but provide the remaining information. NSPs though street-outreach by drugs agency staff; outreach to drug users' homes; delivery to drug user networks through peers (secondary exchange). Mostly, outreach is operated/coordinated from a fixed programme, e.g. drugs agency with NSP. If the number of syringes distributed through street outreach is not available separately, include it under 'Fixed NSPs', indicate under 'number of syringes' not available = XXX, but provide the remaining information.

iv

v

Thank you for providing this information.
Rua Cruz de Santa Apolónia 23-25, 1149-045 Lisbon Portugal

Country Reporting year B (i) Date filled in Name Institution E-mail If YES: Number of different syringe provision points (iii)

GENERAL COMMENT: Not all types of syringe exchange points are available in all countries. For few countries, estimates under 'OVERALL SYSTEM' (Row 29) will be the main information they can provide.

Standard Table 10: Syringe availability
(Reporting Year B)

Number of syringes provided (sold, exchanged, distributed)

Modalities of syringe provision (in percent - 100% across the three columns)

Exch Fixed NSPs (ii) NSP through specially equipped van/bus (iv) NSP through street-outreach, incl. peer-distribution (v) Vending machines Prison NSPs Pharmacy/Drugstore syringe exchange/provision Pharmacy / Drugstore syringe sales to drug users Other 1 <PLEASE SPECIFY under no. 2 below> Other 2 <PLEASE SPECIFY under no. 2 below> Unknown type OVERALL SYSTEM:

Distr

Sale

XXX

XXX XXX 100%

Rua Cruz de Santa Apolónia 23-25, 1149-045 Lisbon Portugal

Number of individual clients of syringe provision in reporting year (see no. 1 below)

Availability in the country (indicate: YES or NO)

Number of client contacts for syringe provision in reporting year (see no. 1 below)

FURTHER INFORMATION:

1

Please provide references to studies on numbers injecting drug users reached by services.

2

Specify other types of syringe provision.

3

Please estimate the national geographical coverage of syringe provision and/or the percentage of injecting drug user population covered.

4

Please indicate your sources of information, including other experts, working groups or committees involved in providing the information for this table

NOTES:

i

This worksheet can be used for reporting data from the year before "Reporting year A". Please put '999' when no information is available and 'XXX' when the category is not applicable. Indicate with an asterisk '*', when the value you provided is an estimate and provide further information on the basis of the estimate under no. 4 above. NSP = Needle and syringe programme, Fixed location: e.g.specialised drug agency, medical/emergency service.

ii

iii

Syringe provision points: individual locations, physically distinct outlets where syringes can be obtained for free, against payment or in exchange against used ones. (e.g. Row 24: Number of pharmacies involved in syringe exchange programmes; Row 25: Total number of pharmacies, in countries where sale of syringes is legal). NSPs from a specially equipped mobile unit (van/bus) that services different locations on a regular basis. Refer in your reply to the number of different sites serviced by mobile unit as 'points'. Most mobile units are linked to and operated from a fixed programme, e.g. drugs agency with NSP. If the number of syringes distributed through the mobile units are not available separately, include the number of syringes provided under 'Fixed NSPs', indicate under 'number of syringes' not available = XXX, but provide the remaining information. NSPs though street-outreach by drugs agency staff; outreach to drug users' homes; delivery to drug user networks through peers (secondary exchange). Mostly, outreach is operated/coordinated from a fixed programme, e.g. drugs agency with NSP. If the number of syringes distributed through street outreach is not available separately, include it under 'Fixed NSPs', indicate under 'number of syringes' not available = XXX, but provide the remaining information. Thank you for providing this information.
Rua Cruz de Santa Apolónia 23-25, 1149-045 Lisbon Portugal

iv

v


								
To top